Ibis Technology Corp, Danvers, Mass., today said that it has licensed from IBM the right to manufacture and sell SIMOX-SOI(Separation by IMplantation of OXygen / Silicon-On-Insulator) wafers, using IBM's proprietary SIMOX process, to IBM and to all Ibis customers.
As part of the agreement, Ibis will grant IBM warrants to purchase Ibis common stock.Ibis is a manufacturer and supplier of SIMOX-SOI implantation equipment and wafers to semiconductor manufacturers.
Under the royalty-bearing license agreement, Ibis may use IBM's process to produce SIMOX-SOI wafers which Ibis will market as Advantox-MLD. A complementary product to their existingAdvantox product line, Advantox-MLD wafers will be broadly marketed to integrated circuit manufacturers looking to accelerate their SOI adoption process, Ibis said.
Under the agreement Ibis grants IBM rights to Ibis patents utilized in the modified low dose ("MLD") process.